| The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. | |
| | |
MedLine Citation:
|
PMID: 18823890 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Increased oxidative stress (SOX), inflammation and prevalence of cardiovascular disease (CVD) have been reported in end-stage renal disease (ESRD), but their associations with kynurenine (KYN) pathway activation remain unknown. We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls. Analysis of TRP degradation through the KYN pathway demonstrated that in uremia the concentrations of this aminoacid were decreased by 40-60% in comparison with controls. In contrast, the plasma levels of KYN and 3-HKYN in ESRD patients were increased by 32-96% and 184-306%, respectively. These changes were accompanied by significant increase in the kyn/trp ratios by 140-240%, and 3-hkyn/kyn ratios by 40-154% in uremics compared to controls. ESRD patients showed a significant increase in Cu/Zn SOD, total peroxide and hs CRP levels between controls and all patients group. KYN and 3-HKYN were positively associated with inflammation and SOX markers in uremics. Logistic regression analysis showed that age, gender, presence of DM (all p<0.001), elevated hs CRP (p<0.01) and 3-HKYN levels (p<0.05) were independently associated with the presence of CVD in this population. These results suggest a relationship between KYN pathway activation and increased SOX, inflammation and CVD prevalence in ESRD patients. |
| | |
Authors:
|
Krystyna Pawlak; Tomasz Domaniewski; Michal Mysliwiec; Dariusz Pawlak |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-08-26 |
Journal Detail:
|
Title: Atherosclerosis Volume: 204 ISSN: 1879-1484 ISO Abbreviation: Atherosclerosis Publication Date: 2009 May |
Date Detail:
|
Created Date: 2009-05-04 Completed Date: 2009-08-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0242543 Medline TA: Atherosclerosis Country: Ireland |
Other Details:
|
Languages: eng Pagination: 309-14 Citation Subset: IM |
Affiliation:
|
Department of Monitored Pharmacotherapy, Medical University, Bialystok, Poland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Age Factors Aged Biological Markers / blood C-Reactive Protein / analysis Cardiovascular Diseases / blood, epidemiology, etiology* Case-Control Studies Cross-Sectional Studies Diabetes Complications / blood, etiology Female Humans Inflammation / blood, epidemiology, etiology* Kidney Failure, Chronic / blood*, complications, epidemiology Kynurenine / analogs & derivatives*, blood Logistic Models Male Middle Aged Oxidative Stress* Peroxides / blood Prevalence Risk Assessment Risk Factors Sex Factors Superoxide Dismutase / blood Tryptophan / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Peroxides; 343-65-7/Kynurenine; 484-78-6/3-hydroxykynurenine; 73-22-3/Tryptophan; 9007-41-4/C-Reactive Protein; EC 1.15.1.1/Superoxide Dismutase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable c...
Next Document: Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-...